Detail
| LncRNA Name | PART1 |
| Synonyms | DKFZP586D0823, NCRNA00206 |
| Region | GRCh38_5:60487713-60547657 Sequence |
| Ensembl | ENSG00000152931 |
| RefSeq | NR_024617 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 M8046/3 |
| Methods | qPCR etc. |
| Sample | NSCLC tissues |
| Expression Pattern | up-regulated |
| Function Description | the expression of PART1 was significantly up-regulated in 73.1% (152/208) stage I-III NSCLC specimens compared with adjacent normal tissues. high tissue PART1 expression indicated poor DFS in stage I-III NSCLC patients. PART1 may prove to be a promising biomarker for prediction of survival and tumor recurrence in stage I-III NSCLC. |
| Pubmed ID | 28819376 |
| Year | 2017 |
| Title | PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancer. |
| External Links |
| Links for PART1 | GenBank HGNC lncrnadb Noncode |
| Links for non small cell lung cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.